European Archives - Page 509 of 1104 - European Medical Journal

A cautionary tale of digital transformation

As the pharmaceutical industry embraces digital transformation, new technologies have the potential to sink or swim. How can the industry ensure it’s backing the most effective innovations and not getting stuck in dead ends?

The future of pharmaceutical sales

The COVID-19 pandemic has reshaped pharmaceutical sales, moving from face-to-face to predominantly digital interactions. How can sales reps adapt to multichannel approaches and enhance performance amidst this shift in sales training and team dynamics?

In data we trust: how to nail consent and preference management

The pharmaceutical industry’s digital transformation during the pandemic has fuelled fresh opportunities to collect and harness data, but this venture must be approached with a strong consideration for consent and preference management rules

EMJ Hematology 9 [Supplement 6] 2021

Presentations on sickle cell disease (SCD) at the European Hematology Association (EHA) Virtual Congress 2021.

Sickle Cell Disease: More Than Just Anaemia

Rachel Kesse-Adu highlighted that the hallmark of sickle cell disease (SCD) is painful vaso-occlusive crises (VOCs). These not only cause…

Amgen's Tamika Jean-Baptiste on creating an equitable experience

An interview with Tamika-Jean Baptiste, Vice President and Chief Diversity Officer, Amgen.

Resilience After Rejection

Rejection is always painful, but it is particularly agonising to have a drug rejected at the point of regulatory approval. After spending months researching, preparing, manufacturing and quality checking a drug, only to be sent back to the drawing board, how can companies get back into their creationary swing straight away?

UTIs: Prevalent Yet Overlooked?

Scientists led a focus group study of 29 females experiencing recurrent UTIs in order to gain insight into the gaps in their care…

The Microbiome: The Answer to Reducing Prostate Cancer Risk?

This breaking research suggests that alterations in diet and lifestyle choices may be able to decrease risks of prostate cancer development…

Getting Down to Business

We speak with Andy Sleet, Managing Partner, OYF Ltd, who tells the story of how his career was turned on its head, steering him into business coaching.